The non-cash exchange of CERO notes for convertible preferred stock adds a large dilutive overhang with no operating cash infusion. Monitor for stockholder approval timeline and any early conversion activity that could pressure the stock. The alternate conversion rights at a discount to VWPA create a structural downward bias if the stock trades below $2.1888.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Aug 31 $1.68entry
- T+1 · 3mo ago −2.98%α −2.29% · $1.63
- T+5 · 3mo ago −5.65%α −5.51% · $1.59
- T+20 · 8w ago −0.60%α −0.66% · $1.67
- T+58 · todayOpen
- T+60 · tomorrow Pending
Price Chart
How similar events traded
Executive Summary
SRX Global issued $2.86M of Series C convertible preferred stock to accredited investors in exchange for assignment of CERO Therapeutics promissory notes, with no new cash proceeds. The preferred stock carries a fixed conversion price of $2.1888 per common share and includes alternate conversion rights at a discount to market price after stockholder approval, creating significant future dilution overhang.
Key Financial Metrics
Key Facts
- Sold 3,579 shares of Series C convertible preferred stock at $1,000 stated value per share for total consideration of $2,862,500
- Purchase price satisfied by assignment of Convertible Grid Promissory Notes issued by CERO Therapeutics Holdings, Inc. (aggregate original principal $2,812,500)
- Fixed conversion price of $2.1888 per common share; alternate optional conversion at 95% of 5-day VWAP and alternate triggering event conversion at 90% of 5-day VWAP (both after stockholder approval)
- Company must seek stockholder approval for issuance of all common shares upon conversion and warrant exercise per NYSE American rules
- Registration rights agreement requires filing of resale registration statement for conversion shares and warrant shares
- Company may redeem all outstanding Series C preferred at 115% of the greater of conversion amount or market-linked value
Financial Impact
Up to ~1.6M common shares issuable upon full conversion of Series C preferred at $2.1888/share, representing material dilution relative to current $35M market cap
Risk Factors
- Significant dilution from conversion of Series C preferred into common stock
- Alternate conversion at 95%/90% of VWPA could accelerate selling pressure
- No new cash raised, the transaction merely swaps one illiquid asset for equity-linked securities
- Stockholder approval required for full conversion rights; failure could trigger triggering events with penalty provisions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-040642 |
| Document: 0001493152-26-040642-index.html | 0001493152-26-040642 |
| Document: 0001493152-26-040642.txt | 0001493152-26-040642 |
Track record
30 reports on SRXH
3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +77.11% at T+60 after the Jun 18, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 20, 20261d ago Press Release Neutral 3/10 Entry $0.8402 Now $0.8000 −4.78% settles Nov 30
- Nov 20, 20261d ago SC 13D Neutral 5/10 Entry $0.9950 Now $0.8000 −19.60% settles Nov 30
- Oct 30, 202622d ago Press Release Neutral 3/10 Entry $1.01 to $0.8116 Now $0.8000 −20.79% ▼ −19.64% −16.94% vs SPY
- Oct 7, 20266w ago 8-K Mixed 6/10 Entry $1.49 to $1.29 Now $0.8000 −46.31% ▼ −13.42% −12.44% vs SPY
- Oct 6, 20266w ago 8-K Neutral 4/10 Entry $1.49 to $1.29 Now $0.8000 −46.31% ▼ −13.42% −12.44% vs SPY
- Sep 24, 20268w ago Press Release Neutral 3/10 Entry $1.73 to $1.61 Now $0.8000 −53.76% ▼ −6.94% −6.52% vs SPY
- Sep 9, 202610w ago 8-K Neutral 3/10 Entry $1.51 to $1.60 Now $0.8000 −47.02% ▲ +5.96% +6.62% vs SPY
- Sep 2, 202611w ago 8-K Neutral 5/10 Entry $1.56 to $1.59 Now $0.8000 −48.72% ▲ +1.92% +3.07% vs SPY
- Aug 28, 202612w ago 8-K Bearish 5/10 Viewing Entry $1.68 to $1.59 Now $0.8000 +52.38% ▲ +5.65% +5.51% vs SPY
- Aug 19, 202613w ago 8-K Mixed 5/10 Entry $1.87 to $1.84 Now $0.8000 −57.22% ▼ −1.60% −1.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers